Literature DB >> 1696640

Neutralization epitopes on rotavirus SA11 4fM outer capsid proteins.

M Gorziglia1, G Larralde, R L Ward.   

Abstract

The VP7 and VP4 genes of seven antigenic mutants of simian rotavirus SA11 4fM (serotype 3) selected after 39 passages in the presence of SA11 4fM hyperimmune antiserum, were sequenced. Nucleotide sequence analysis indicated the following. (i) Twice as many amino acid substitutions occurred in the VP7 protein than in VP4, which has a molecular weight twice that of VP7. (ii) Most amino acid changes that occurred clustered in six variable regions of VP7 and in two variable regions of VP4; these variable regions may represent immunodominant epitopes. (iii) Most amino acid substitutions that occurred in VP7 and VP4 of these mutants were also observed in antigenic mutants selected with neutralizing monoclonal antibodies (NMAbs); however, some amino acid substitutions occurred that were not selected for NMAbs. (iv) On VP7, some of the neutralization epitopes appeared to be interrelated because amino acid substitution in one site affected binding of specific NMAbs to other sites, while other neutralization epitopes on VP7 appeared to be independent, in that amino acid substitution in one site did not affect the binding of NMAbs to another distant site.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1696640      PMCID: PMC247924     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  Derivation of neutralizing monoclonal antibodies to human rotaviruses and evidence that an immunodominant neutralization site is shared between serotypes 1 and 3.

Authors:  B S Coulson; J M Tursi; W J McAdam; R F Bishop
Journal:  Virology       Date:  1986-10-30       Impact factor: 3.616

2.  Direct serotyping of human rotavirus in stools by an enzyme-linked immunosorbent assay using serotype 1-, 2-, 3-, and 4-specific monoclonal antibodies to VP7.

Authors:  K Taniguchi; T Urasawa; Y Morita; H B Greenberg; S Urasawa
Journal:  J Infect Dis       Date:  1987-06       Impact factor: 5.226

3.  Primary structure of the cleavage site associated with trypsin enhancement of rotavirus SA11 infectivity.

Authors:  S López; C F Arias; J R Bell; J H Strauss; R T Espejo
Journal:  Virology       Date:  1985-07-15       Impact factor: 3.616

4.  Cross-reactive and serotype-specific neutralization epitopes on VP7 of human rotavirus: nucleotide sequence analysis of antigenic mutants selected with monoclonal antibodies.

Authors:  K Taniguchi; Y Hoshino; K Nishikawa; K Y Green; W L Maloy; Y Morita; S Urasawa; A Z Kapikian; R M Chanock; M Gorziglia
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

5.  Characterization of homotypic and heterotypic VP7 neutralization sites of rhesus rotavirus.

Authors:  E R Mackow; R D Shaw; S M Matsui; P T Vo; D A Benfield; H B Greenberg
Journal:  Virology       Date:  1988-08       Impact factor: 3.616

6.  Identification of cross-reactive and serotype 2-specific neutralization epitopes on VP3 of human rotavirus.

Authors:  K Taniguchi; W L Maloy; K Nishikawa; K Y Green; Y Hoshino; S Urasawa; A Z Kapikian; R M Chanock; M Gorziglia
Journal:  J Virol       Date:  1988-07       Impact factor: 5.103

7.  VP4 protein of porcine rotavirus strain OSU expressed by a baculovirus recombinant induces neutralizing antibodies.

Authors:  K Nishikawa; N Fukuhara; F Liprandi; K Green; A Z Kapikian; R M Chanock; M Gorziglia
Journal:  Virology       Date:  1989-12       Impact factor: 3.616

8.  Rotavirus VP7 neutralization epitopes of serotype 3 strains.

Authors:  K Nishikawa; Y Hoshino; K Taniguchi; K Y Green; H B Greenberg; A Z Kapikian; R M Chanock; M Gorziglia
Journal:  Virology       Date:  1989-08       Impact factor: 3.616

9.  Glycosylation, an important modifier of rotavirus antigenicity.

Authors:  J Caust; M L Dyall-Smith; I Lazdins; I H Holmes
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

10.  Molecular basis of rotavirus virulence: role of gene segment 4.

Authors:  P A Offit; G Blavat; H B Greenberg; H F Clark
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

View more
  18 in total

1.  The rhesus rotavirus VP4 sialic acid binding domain has a galectin fold with a novel carbohydrate binding site.

Authors:  Philip R Dormitzer; Zhen-Yu J Sun; Gerhard Wagner; Stephen C Harrison
Journal:  EMBO J       Date:  2002-03-01       Impact factor: 11.598

2.  Simian rotavirus SA11 strains.

Authors:  S López; C F Arias
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

3.  Rotavirus YM gene 4: analysis of its deduced amino acid sequence and prediction of the secondary structure of the VP4 protein.

Authors:  S López; I López; P Romero; E Méndez; X Soberón; C F Arias
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

4.  Serotype-specific epitope(s) present on the VP8 subunit of rotavirus VP4 protein.

Authors:  G Larralde; B G Li; A Z Kapikian; M Gorziglia
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

5.  Relation of VP7 amino acid sequence to monoclonal antibody neutralization of rotavirus and rotavirus monotype.

Authors:  B S Coulson; C Kirkwood
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

6.  Localization of rotavirus VP4 neutralization epitopes involved in antibody-induced conformational changes of virus structure.

Authors:  Y J Zhou; J W Burns; Y Morita; T Tanaka; M K Estes
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

7.  Nucleotide sequence and expression in E. coli of the complete P4 type VP4 from a G2 serotype human rotavirus.

Authors:  N P Mahajan; C D Rao
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

8.  Development of Stable Rotavirus Reporter Expression Systems.

Authors:  Yuta Kanai; Takahiro Kawagishi; Ryotaro Nouda; Misa Onishi; Pimfhun Pannacha; Jeffery A Nurdin; Keiichiro Nomura; Yoshiharu Matsuura; Takeshi Kobayashi
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

9.  Multiple Introductions and Antigenic Mismatch with Vaccines May Contribute to Increased Predominance of G12P[8] Rotaviruses in the United States.

Authors:  Kristen M Ogden; Yi Tan; Asmik Akopov; Laura S Stewart; Rendie McHenry; Christopher J Fonnesbeck; Bhinnata Piya; Maximilian H Carter; Nadia B Fedorova; Rebecca A Halpin; Meghan H Shilts; Kathryn M Edwards; Daniel C Payne; Mathew D Esona; Slavica Mijatovic-Rustempasic; James D Chappell; John T Patton; Natasha B Halasa; Suman R Das
Journal:  J Virol       Date:  2018-12-10       Impact factor: 5.103

10.  Isolation of a human rotavirus containing a bovine rotavirus VP4 gene that suppresses replication of other rotaviruses in coinfected cells.

Authors:  R L Ward; Q Jin; O Nakagomi; D S Sander; J R Gentsch
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.